Shi‐Jun Xu

449 total citations
27 papers, 307 citations indexed

About

Shi‐Jun Xu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Shi‐Jun Xu has authored 27 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Shi‐Jun Xu's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), MicroRNA in disease regulation (3 papers) and Renal cell carcinoma treatment (2 papers). Shi‐Jun Xu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), MicroRNA in disease regulation (3 papers) and Renal cell carcinoma treatment (2 papers). Shi‐Jun Xu collaborates with scholars based in China, South Korea and Egypt. Shi‐Jun Xu's co-authors include Suhwan Chang, Hong-Tao Hu, Hui Zhou, Shu‐Juan Xie, Hui Xu, Yin Zhang, Jianhua Yang, Liang‐Hu Qu, Hongtao Hu and Weiqi Zhang and has published in prestigious journals such as Journal of Molecular Biology, International Journal of Molecular Sciences and Cell Death and Differentiation.

In The Last Decade

Shi‐Jun Xu

27 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shi‐Jun Xu China 10 147 85 46 40 40 27 307
Jiamin Zhou China 11 110 0.7× 56 0.7× 48 1.0× 29 0.7× 40 1.0× 23 323
Mingsen Li China 13 220 1.5× 85 1.0× 57 1.2× 25 0.6× 22 0.6× 30 422
Xinyue Lv China 10 160 1.1× 75 0.9× 44 1.0× 134 3.4× 28 0.7× 27 366
Rachel Howarth United Kingdom 9 163 1.1× 56 0.7× 116 2.5× 78 1.9× 83 2.1× 14 423
T. Okano Japan 10 136 0.9× 48 0.6× 32 0.7× 144 3.6× 24 0.6× 36 422
Rania H. Mahmoud Egypt 10 156 1.1× 184 2.2× 54 1.2× 47 1.2× 13 0.3× 23 324
Hei Jung Kim South Korea 10 145 1.0× 48 0.6× 26 0.6× 71 1.8× 14 0.3× 15 314
Henry Kuang United States 9 128 0.9× 40 0.5× 98 2.1× 50 1.3× 25 0.6× 12 277
Le Ma China 12 149 1.0× 49 0.6× 60 1.3× 43 1.1× 77 1.9× 26 371

Countries citing papers authored by Shi‐Jun Xu

Since Specialization
Citations

This map shows the geographic impact of Shi‐Jun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi‐Jun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi‐Jun Xu more than expected).

Fields of papers citing papers by Shi‐Jun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi‐Jun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi‐Jun Xu. The network helps show where Shi‐Jun Xu may publish in the future.

Co-authorship network of co-authors of Shi‐Jun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shi‐Jun Xu. A scholar is included among the top collaborators of Shi‐Jun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi‐Jun Xu. Shi‐Jun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Cheng, et al.. (2025). Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer’s Disease. International Journal of Molecular Sciences. 26(1). 403–403. 9 indexed citations
2.
Tang, Qiang, et al.. (2024). TCM-ADIP: A Multidimensional Database Linking Traditional Chinese Medicine to Functional Brain Zones of Alzheimer’s Disease. Journal of Molecular Biology. 437(6). 168874–168874. 1 indexed citations
4.
Luo, Wenjun, Haijun Zhang, Hao Zhang, et al.. (2024). Reposition: Focalizing β-Alanine Metabolism and the Anti-Inflammatory Effects of Its Metabolite Based on Multi-Omics Datasets. International Journal of Molecular Sciences. 25(19). 10252–10252. 3 indexed citations
5.
6.
Xu, Shi‐Jun, Jinhua Chen, Suhwan Chang, & Hailiang Li. (2024). The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. Frontiers in Immunology. 14. 1320305–1320305. 8 indexed citations
7.
Sun, Xiaoyi, et al.. (2023). Integrative multi‐omics analysis reveals the critical role of the PBXIP1 gene in Alzheimer's disease. Aging Cell. 23(2). e14044–e14044. 8 indexed citations
8.
Chen, Xinzhe, Xinmin Li, Shi‐Jun Xu, et al.. (2023). TMEM11 regulates cardiomyocyte proliferation and cardiac repair via METTL1-mediated m7G methylation of ATF5 mRNA. Cell Death and Differentiation. 30(7). 1786–1798. 29 indexed citations
9.
Guo, Yuan, Weijun Fan, Shi‐Jun Xu, et al.. (2022). Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective study. Frontiers in Oncology. 12. 961394–961394. 15 indexed citations
10.
Xu, Shi‐Jun, Yuan Guo, Hongtao Hu, et al.. (2022). Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinoma. Frontiers in Oncology. 12. 1014653–1014653. 2 indexed citations
11.
Liu, Jinxing, Ang Gao, Yan Liu, et al.. (2022). MicroRNA Expression Profiles of Epicardial Adipose Tissue-Derived Exosomes in Patients with Coronary Atherosclerosis. Reviews in Cardiovascular Medicine. 23(6). 206–206. 7 indexed citations
12.
Hu, Hongtao, Jung‐Hoon Park, Zhe Wang, et al.. (2021). Localized Photothermal Ablation Therapy of Obstructive Rectal Cancer Using a Nanofunctionalized Stent in a Mouse Model. ACS Biomaterials Science & Engineering. 7(12). 5890–5898. 9 indexed citations
13.
Zhang, Xiuqing, Shi‐Jun Xu, Peng Gao, et al.. (2021). A pro-inflammatory mediator USP11 enhances the stability of p53 and inhibits KLF2 in intracerebral hemorrhage. Molecular Therapy — Methods & Clinical Development. 21. 681–692. 23 indexed citations
14.
Zhang, Yin, Peipei Chen, Hui Xu, et al.. (2021). Genome-wide identification of microRNA targets reveals positive regulation of the Hippo pathway by miR-122 during liver development. Cell Death and Disease. 12(12). 1161–1161. 12 indexed citations
15.
Hu, Hongtao, Zhe Wang, Myung Ji Kim, et al.. (2020). The Establishment of a Fast and Safe Orthotopic Colon Cancer Model Using a Tissue Adhesive Technique. Cancer Research and Treatment. 53(3). 733–743. 6 indexed citations
16.
Liu, Litao, Yingqi Song, Yin Liu, et al.. (2019). Morphine‐induced RACK1‐dependent autophagy in immortalized neuronal cell lines. British Journal of Pharmacology. 177(7). 1609–1621. 15 indexed citations
17.
Xu, Hui, Shi‐Jun Xu, Shu‐Juan Xie, et al.. (2019). MicroRNA-122 supports robust innate immunity in hepatocytes by targeting the RTKs/STAT3 signaling pathway. eLife. 8. 34 indexed citations
18.
Guan, Fei, et al.. (2018). Influence of blood glucose level on the prognosis of patients with diabetes mellitus complicated with ischemic stroke. Journal of Research in Medical Sciences. 23(1). 10–10. 12 indexed citations
19.
Xu, Shi‐Jun, Li Zhang, Xiuqing Zhang, et al.. (2016). Serum Resistin Levels May Contribute to an Increased Risk of Acute Cerebral Infarction. Molecular Neurobiology. 54(3). 1919–1926. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026